Editas Medicine, Inc.
EDITFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
32
Cost of Revenue
0
Gross Profit
32
Gross Margin
100.0%
Operating Income
-251
Operating Margin
-777.2%
Net Income
-237
Net Margin
-733.7%
EPS (Basic)
$-2.88
EPS (Diluted)
$-2.88
EBITDA
-233
EBITDA Margin
-721.4%
2023
12/31/2023
Revenue
78
Cost of Revenue
6
Gross Profit
72
Gross Margin
92.2%
Operating Income
-169
Operating Margin
-216.6%
Net Income
-153
Net Margin
-196.1%
EPS (Basic)
$-2.02
EPS (Diluted)
$-2.02
EBITDA
-163
EBITDA Margin
-208.8%
2022
12/31/2022
Revenue
20
Cost of Revenue
6
Gross Profit
13
Gross Margin
67.9%
Operating Income
-226
Operating Margin
-1146.3%
Net Income
-220
Net Margin
-1118.3%
EPS (Basic)
$-3.21
EPS (Diluted)
$-3.21
EBITDA
-220
EBITDA Margin
-1114.1%
2021
12/31/2021
Revenue
26
Cost of Revenue
5
Gross Profit
20
Gross Margin
80.2%
Operating Income
-193
Operating Margin
-756.1%
Net Income
-193
Net Margin
-753.6%
EPS (Basic)
$-2.85
EPS (Diluted)
$-2.85
EBITDA
-188
EBITDA Margin
-736.3%
2020
12/31/2020
Revenue
91
Cost of Revenue
158
Gross Profit
-67
Gross Margin
-74.1%
Operating Income
-135
Operating Margin
-148.6%
Net Income
-116
Net Margin
-127.8%
EPS (Basic)
$-1.98
EPS (Diluted)
$-1.98
EBITDA
-131
EBITDA Margin
-144.3%